EXTX — Exact Therapeutics AS Share News
0.000.00%
Last trade - 00:00- NOK78.08m
- NOK29.04m
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial
Brief: Exact Therapeutics Announces Grant Of Key Patent In Japan
Brief: Exact, Cordance Medical Announce Early Data In Brain Cancer Mice Model
Brief: FDA Clears IND Application For Exact Therapeutics' Phase 2 ENACT Trial
Brief: Exact Therapeutics' Private Placement Successfully Placed
Brief: Exact Therapeutics Gets Investment From GE Healthcare
Brief: Exact Therapeutics: Contemplated Private Placement
Brief: Exact Therapeutics Starts Collaboration With Agenus
Brief: Exact Therapeutics H1 Pre-Tax Loss NOK 29.3 Million
Brief: Exact Therapeutics - Grant Of Immunotherapy Patent
Brief: Exact Therapeutics Says With FDA's Guidance, Co Will Now Focus On Enact Trial ,Stop Recruitment Into Activate Trial
Brief: Exact Therapeutics Raises NOK 25 Mln In Private Placement
Brief: Exact Therapeutics Contemplates Private Placement
Brief: Exact Therapeutics H1 Net Loss Narrows To NOK 22.8 Mln
Brief: Exact Therapeutics Announces Positive Clinical Results From ACTIVATE Phase I Dose Escalation
Brief: Exact Therapeutics Announces Partnership With Cordance Medical